DNA Damage Response Proteins and Oxygen Modulate Prostaglandin E2 Growth Factor Release in Response to Low and High LET Ionizing Radiation

Calderwood, 2013, Tumor heterogeneity, clonal evolution, and therapy resistance: an opportunity for multitargeting therapy, Discov Med, 15, 188

Huang, 2011, Caspase-mediated paracrine signaling from dying cells potently stimulate tumor cell repopulation during cancer radiotherapy, Nat Med, 17, 860, 10.1038/nm.2385

Ng, 2013, Molecular mechanisms involved in tumor repopulation after radiotherapy, Transl Cancer Res, 2, 442, 10.3978/j.issn.2218-676X.2013.10.03

Zimmerman, 2013, Cell death-stimulated cell proliferation: a tissue regeneration mechanism usurped by tumors during radiotherapy, Semin Radiat Oncol, 23, 288, 10.1016/j.semradonc.2013.05.003

Li, 2013, PGE2 promotes renal carcinoma cell invasion through activated RalA, Oncogene, 32, 1408, 10.1038/onc.2012.161

Generali, 2014, COX-2 expression is predictive for early relapse and aromatase inhibitor resistance in patients with ductal carcinoma in situ of the breast, and is a target for treatment, Br J Cancer, 111, 46, 10.1038/bjc.2014.236

Kurtova, 2015, Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance, Nature, 517, 209, 10.1038/nature14034

Stracker, 2009, Taking the time to make important decisions: the checkpoint effector kinases Chk1 and Chk2 and the DNA damage response, DNA Repair, 8, 1047, 10.1016/j.dnarep.2009.04.012

Ciccia, 2010, The DNA damage response: making it safe to play with knives, Mol Cell, 40, 179, 10.1016/j.molcel.2010.09.019

Reinhardt, 2009, Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2, Curr Opin Cell Biol, 21, 245, 10.1016/j.ceb.2009.01.018

Putnam, 2009, Perspectives on the DNA damage and replication checkpoint responses in Saccharomyces cerevisiae, DNA Repair, 8, 974, 10.1016/j.dnarep.2009.04.021

Peng, 2010, Repo-man controls a protein phosphatase 1-dependent threshold for DNA damage checkpoint activation, Curr Biol, 20, 387, 10.1016/j.cub.2010.01.020

Fernet, 2010, Control of the G2/M checkpoints after exposure to low doses of ionising radiation: implications for hyper-radiosensitivity, DNA Repair, 9, 48, 10.1016/j.dnarep.2009.10.006

Allen, 2011, More forks on the road to replication stress recovery, J Mol Cell Biol, 3, 4, 10.1093/jmcb/mjq049

Kastan, 2001, ATM – a key determinant of multiple cellular responses to irradiation, Acta Oncol, 40, 686, 10.1080/02841860152619089

Kitagawa, 2004, Phosphorylation of SMC1 is a critical downstream event in the ATM-NBS1-BRCA1 pathway, Genes Dev, 18, 1423, 10.1101/gad.1200304

Baskaran, 1997, Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation, Nature, 387, 516, 10.1038/387516a0

Burma, 2001, ATM phosphorylates histone H2AX in response to DNA double-strand breaks, J Biol Chem, 276, 42462, 10.1074/jbc.C100466200

Chen, 2007, Ataxia telangiectasia mutated (ATM) is essential for DNA-PKcs phosphorylations at the Thr-2609 cluster upon DNA double strand break, J Biol Chem, 282, 6582, 10.1074/jbc.M611605200

Shrivastav, 2009, DNA-PKcs and ATM co-regulate DNA double-strand break repair, DNA Repair, 8, 920, 10.1016/j.dnarep.2009.05.006

Yajima, 2006, ATR-dependent DNA-PKcs phosphorylation in response to UV-induced replication stress, Mol Cell Biol, 26, 7520, 10.1128/MCB.00048-06

Matsuoka, 2007, ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage, Science, 316, 1160, 10.1126/science.1140321

Shaheen, 2011, Synthetic lethality: exploiting the addiction of cancer to DNA repair, Blood, 117, 6074, 10.1182/blood-2011-01-313734

Kelley, 2014, Targeting DNA repair pathways for cancer treatment: what’s new?, Future Oncol, 10, 1215, 10.2217/fon.14.60

Hosoya, 2014, Targeting DNA damage response in cancer therapy, Cancer Sci, 105, 370, 10.1111/cas.12366

Basu, 2012, Targeting the DNA damage response in oncology: past, present and future perspectives, Curr Opin Oncol, 24, 316, 10.1097/CCO.0b013e32835280c6

Li, 2010, Apoptotic cells activate the “phoenix rising” pathway to promote wound healing and tissue regeneration, Sci Signal, 3, ra13, 10.1126/scisignal.2000634

Keysar, 2013, A patient tumor transplant model of squamous cell cancer identifies PI3K inhibitors as candidate therapeutics in defined molecular bins, Mol Oncol, 7, 776, 10.1016/j.molonc.2013.03.004

Skehan, 1990, New colorimetric cytotoxicity assay for anticancer-drug screening, J Natl Cancer Inst, 82, 1107, 10.1093/jnci/82.13.1107

Hawkey, 2001, COX-1 and COX-2 inhibitors, Best Pract Res Clin Gastroenterol, 15, 801, 10.1053/bega.2001.0236

Okayasu, 2006, Repair of DNA damage induced by accelerated heavy ions in mammalian cells proficient and deficient in the non-homologous end-joining pathway, Radiat Res, 165, 59, 10.1667/RR3489.1

Hirakawa, 2015, The combination of Hsp90 inhibitor 17AAG and heavy-ion irradiation provides effective tumor control in human lung cancer cells, Cancer Med, 4, 426, 10.1002/cam4.377

Wang, 2014, Heavier ions with a different linear energy transfer spectrum kill more cells due to similar interference with the Ku-dependent DNA repair pathway, Radiat Res, 182, 458, 10.1667/RR13857.1

Shieh, 2000, The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites, Genes Dev, 14, 289, 10.1101/gad.14.3.289

Anderson, 2013, The dual pathway inhibitor rigosertib is effective in direct patient tumor xenografts of head and neck squamous cell carcinomas, Mol Cancer Ther, 12, 1994, 10.1158/1535-7163.MCT-13-0206

Jimeno, 2013, Phase I study of the hedgehog pathway inhibitor IPI-926 in adult patients with solid tumors, Clin Cancer Res, 19, 2766, 10.1158/1078-0432.CCR-12-3654

Keysar, 2013, Hedgehog signaling alters reliance on EGF receptor signaling and mediates anti-EGFR therapeutic resistance in head and neck cancer, Cancer Res, 73, 3381, 10.1158/0008-5472.CAN-12-4047

Connell, 2011, A downside to apoptosis in cancer therapy?, Nat Med, 17, 780, 10.1038/nm0711-780

Labi, 2015, How cell death shapes cancer, Cell Death Dis, 6, e1675, 10.1038/cddis.2015.20

Liu, 2015, Caspase-3 promotes genetic instability and carcinogenesis, Mol Cell, 58, 284, 10.1016/j.molcel.2015.03.003

Rich, 2000, Defying death after DNA damage, Nature, 407, 777, 10.1038/35037717

McCool, 2012, DNA damage-dependent NF-kappaB activation: NEMO turns nuclear signaling inside out, Immunol Rev, 246, 311, 10.1111/j.1600-065X.2012.01101.x

Dent, 2003, Stress and radiation-induced activation of multiple intracellular signaling pathways, Radiat Res, 159, 283, 10.1667/0033-7587(2003)159[0283:SARIAO]2.0.CO;2

Basu, 1998, The DNA-dependent protein kinase participates in the activation of NFkB following DNA damage, Biochem Biophys Res Commun, 247, 79, 10.1006/bbrc.1998.8741

Sabatel, 2011, Importance of PIKKs in NF-kappaB activation by genotoxic stress, Biochem Pharmacol, 82, 1371, 10.1016/j.bcp.2011.07.105

Tsatsanis, 2006, Signalling networks regulating cyclooxygenase-2, Int J Biochem Cell Biol, 38, 1654, 10.1016/j.biocel.2006.03.021

Donato, 2014, Caspase 3 promotes surviving melanoma tumor cell growth after cytotoxic therapy, J Invest Dermatol, 134, 1686, 10.1038/jid.2014.18

Zhang, 2015, Increased HMGB1 and cleaved caspase-3 stimulate the proliferation of tumor cells and are correlated with the poor prognosis in colorectal cancer, J Exp Clin Cancer Res, 34, 10.1186/s13046-015-0166-1

Hu, 2014, Elevated cleaved caspase-3 is associated with shortened overall survival in several cancer types, Int J Clin Exp Pathol, 7, 5057

Yang, 2014, Effect of celecoxib on inhibiting tumor repopulation during radiotherapy in human FaDu squamous cell carcinoma, Contemp Oncol (Pozn), 18, 260, 10.5114/wo.2014.43932

Inoue, 2013, Inhibition of COX-2 expression by topical diclofenac enhanced radiation sensitivity via enhancement of TRAIL in human prostate adenocarcinoma xenograft model, BMC Urol, 13, 1, 10.1186/1471-2490-13-1

Allen, 2011, Heavy charged particle radiobiology: using enhanced biological effectiveness and improved beam focusing to advance cancer therapy, Mutat Res, 711, 150, 10.1016/j.mrfmmm.2011.02.012